The rapid emergence of antimicrobial resistance is a major threat to human health. Antibiotics modulate a wide range of biological processes in bacteria and as such, the study of bacterial cellular signaling could aid the development of urgently needed new antibiotic agents. Due to the advances in bacterial phosphoproteomics, such a system-wide analysis of bacterial signaling in response to antibiotics has recently become feasible. Here we present a dynamic view of differential protein phosphorylation upon antibiotic treatment and antibiotic resistance. Most strikingly, differential phosphorylation was observed on highly conserved residues of resistance regulating transcription factors, implying a previously unanticipated role of phosphorylation mediated regulation. Using the comprehensive phosphoproteomics data presented here as a resource, future research can now focus on deciphering the precise signaling mechanisms contributing to resistance, eventually leading to alternative strategies to combat antimicrobial resistance. by guest on October 31, 2018 http://www.mcponline.org/ Downloaded from While the characterization of resistance genes was already made possible by advances in functional metagenomic approaches, these methods cannot quantify proteins and decipher the potential bacterial signaling cascades involved in AMR. The study of bacterial cellular signaling in AMR by guest on October 31, 2018 http://www.mcponline.org/ Downloaded from by guest on October 31, 2018 http://www.mcponline.org/ Downloaded from 6 positive strain, despite the lack of a clear resistant phenotype, indicating that changes in signaling precede resistance development.
Introduction
Antimicrobial resistance (AMR) has become one of the most serious threats to global health. At the rate at which resistance against antibiotics is currently rising it is not inconceivable that we will be confronted with a situation in which the actual last resort antibiotics become ineffective. It is estimated that AMR could cause 10 million deaths every year by the year 2050 (1) . In order to effectively combat the threat of AMR, understanding of the molecular mechanisms underlying resistance acquisition is essential.
The noun antibiotic, first described in 1941 by Selman Waksman, represents any small molecule made by a microbe that inhibits the growth of other microbes (2), but an alternative view of antibiotics envisions them as signaling molecules (3) (4) (5) . The antibiotic colistin is a cationic cyclic decapeptide with a lipophilic fatty acyl side chain which is used as a last resort antibiotic for the treatment of multidrug resistant Gram negative infections (6) . Alarmingly, a plasmid-mediated colistin resistance mechanism (mcr-1 gene) has been reported in over 30 countries across five continents since it was first identified in 2015, raising major public health concern (7-9).
Ciprofloxacin is another critically important antimicrobial with possible serious side effects (10) used to treat infections resistant to safer antibiotics. Ciprofloxacin is one of the most commonly prescribed fluoroquinolones in current medical practice and its resistance rate has raised from 1.8 to 15.9 % over only 10 years (11) . Overall, the worldwide spread of AMR in recent years is a sobering reminder of our need to better understand resistance mechanisms in order to design new effective inhibitors. and AMR acquisition could thus provide opportunities for the development of new therapeutic strategies. Bacteria are capable of modifying serine/threonine/tyrosine residues on proteins like eukaryotes, but in addition use two-component signaling which relies on histidine autophosphorylation of sensory kinases as the first component and aspartate phosphorylation of response regulators as the second component (12) . Reversible protein phosphorylation is a wellestablished mechanism of regulating gene expression in response to a variety of environmental stress factors (13) and in recent years, growing evidence has linked two-component systems as well as Serine/Threonine/Tyrosine kinase signaling to AMR (13) (14) (15) . While mass spectrometrybased proteomics has enabled the study of signaling dynamics on a global scale through the quantification of site-specific protein phosphorylation in eukaryotes, the study of bacterial phospho-signaling has largely lagged behind due to technical hurdles. Our recent developments in this area enable us to reach in-depth coverage of bacterial phosphoproteomes (16, 17) , offering the unprecedented opportunity to study signaling mechanisms during antibiotic treatment, resistance acquisition and full resistance.
Here we set out to detect changes in proteome and phosphoproteome of antibiotic treated bacteria in order to detect regulated expression and signaling which correlates with antibiotic susceptibility.
To this end we treated E. coli with increasing doses of ciprofloxacin or colistin for several days, in order to decrease the susceptibility to the antibiotic. In the case of colistin, we also analyzed the were collected by centrifugation at 3000 g at 4°C for 15 minutes. The cell pellets were washed twice with ice-cold PBS and stored at -80 °C until further processes.
Cell lysis and protein extraction. All different E. coli cells with varied MICs to ciprofloxacin or colistin were lysed as described previously (16, 17) . Briefly, cell pellets were resuspended with lysis buffer (100mM Tris-HCl pH 8.5, 7 M Urea, 1% SDC (Sigma-Aldrich), 5 mM TCEP, 30 mM CAA, 10 U/ml DNase I, 1 mM magnesium chloride (Sigma Aldrich), 1% benzonase (Merck Millipore), phosphoSTOP (Roche) and complete mini EDTA free (Roche)) and lyzed by sonication for 45 minutes (20 seconds on, 40 seconds off) using a Bioruptor Plus. Cell debris was removed by ultracentrifugation (140 000g for 1h at 4°C). 1% benzonase was added to the supernatant and the mixture was incubated at room temperature for 2h. Protein concentration was determined by a Bradford protein assay (Bio-Rad) using bovine serum albumin (BSA) as the protein standard. Impurities were removed by methanol/chloroform protein precipitation as follows: 1 mL of supernatant was mixed with 4 mL of methanol (Sigma-Aldrich), 1 mL chloroform (Sigma-Aldrich) and 3 mL ultrapure water with thorough vortexing after each addition. The mixture was then centrifuged for 10 min at 5,000 rpm at room temperature (RT). The upper layer was discarded and 3 mL of methanol was added. After sonication and centrifugation (5,000 rpm, 10 min at RT), the solvent was removed and the precipitate was allowed to air dry. The pellet was and peptides were eluted with 30% acetonitrile (Sigma). Eluted peptides were subsequently dried down using a lyophilizer and subjected to proteome analysis or phosphopeptide enrichment.
Fe 3+ -IMAC phosphopeptide enrichment. Enrichments were performed as previously described (17) . Briefly, lyophilized peptides were dissolved in buffer containing 30% acetonitrile and 0.07% trifluoroacetic acid (TFA, Sigma-Aldrich)) and the pH was adjusted to a value of 2.3 using 10% TFA prior to injection onto the Fe 3+ -IMAC column (Propac IMAC-10 4 x 50 mm column, Thermofisher scientific). The elution buffer is composed of 0.3% NH4OH. UV-abs signal was recorded at the outlet of the column, at a wavelength of 280 nm. Collected phosphopeptides were immediately frozen in liquid nitrogen and subsequently dried down using a lyophilizer. Peptides were then transferred to an analytical column (75 μm x 60 cm Poroshell 120 EC-C18, 2.7 μm, Agilent Technology, packed in-house) prior to separation at room temperature at a flow rate of 300 nL/min using a 115 minutes linear gradient, from 13% to 44% buffer B (0.1 % FA, 80 % ACN). Electrospray ionization was performed using 1.9 kV spray voltage and a capillary temperature of 320 °C. The mass spectrometer was operated in data-dependent acquisition mode:
LC
full scan MS spectra (m/z 375 -1,600) were acquired in the Orbitrap at 60,000 resolution for a maximum injection time of 20 ms with an AGC target value of 3e 6 . Up to 12 precursors were selected for subsequent fragmentation and high-resolution HCD MS2 spectra were generated using a normalized collision energy of 27 %. The intensity threshold to trigger MS2 spectra was set to 2e 5 , and the dynamic exclusion to 15 seconds. MS2 scans were acquired in the Orbitrap mass analyzer at a resolution of 30,000 (isolation window of 1.4 Th) with an AGC target value of 1e 5 charges and a maximum ion injection time of 50 ms. Precursor ions with unassigned charge state as well as charge state of 1+ or superior/equal to 6+ were excluded from fragmentation.
Data Analysis. MaxQuant software (version 1.6.0.1) was used to process the raw data files, which were searched against the database merging reviewed E. coli K12 sequences (E.coli K12 Uniprot database, March 2016, 4434 entries) and mcr-1 strain sequences (5005 entries) and removing duplicates, with the following parameters: trypsin digestion (cleavage after lysine and arginine residues, even when followed by proline) with a maximum of 3 missed cleavages, fixed carbamidomethylation of cysteine residues and variable modifications of methionine oxidation and Protein N-terminal acetylation (19) . In case of phosphoproteome analysis, the variable modification of phosphorylation on serine, threonine, tyrosine, histidine, and aspartate residues was also included. Mass tolerance was set to 4.5 ppm at the MS1 level and 20 ppm at the MS2 level. The False Discovery Rate (FDR) was set to 1% at the peptide and protein level, an additional peptide score cut-off of 40 was used for modified peptides and the minimum peptide length was set to 7 residues. In terms of label-free quantification analysis, the match between runs (MBR) function was used with the retention time window of 1 minutes. The MaxQuant output tables "evidence.txt" and "phospho (HDSTY)Sites.txt" from phosphoproteome dataset and "proteinGroups.txt" from proteome datasets were further used to calculate the identification number of unique phosphopeptides, phosphosites, and proteins. The table of phospho (HDSTY)Sites.txt and "proteinGroups.txt" were further used for quantification analysis at phosphoproteome and proteome level, respectively, using Perseus (version 1.6.0.2) (20) . using ClueGO app in Cytoscape (version 3.5.1) with the p-value <0.05 (21) . Phosphorylation motifs were analyzed using the Motif-algorithm with occurrences set to 10 and significance set to 0.00001, using the whole genome sequence as background (22) . Sequence logos were generated by iceLogo (23) . For protein sequence alignment, full-length protein sequences were aligned using the Clustal X program with default settings and after alignment, phosphosite regions were displayed. All protein sequences from the same gene in different gram-negative bacteria, relatively close to E. coli., were download from Uniprot.
Experiment design and statistical rationale.
Each sample was enriched in triplicate before being injected separately into the LC-MS/MS system. Each raw file was separately processed using the MaxQuant software. Triplicate analysis was sufficient to saturate the number of phosphosites detected.
Results

Proteome profiling demonstrates differential protein expression triggered by continuous exposure to antibiotics
Wild-type E. coli cells were continuously exposed to low dosage, corresponding to one-quarter of the Minimum Inhibitory Concentration (MIC), of either colistin or ciprofloxacin to decrease the antibiotic susceptibility and trigger AMR ( Fig. 1A ). For ciprofloxacin we indeed observed a rapid increase in MIC, resulting in a 8-fold higher MIC after 3 days and a 64-fold higher MIC after 7 days ( Fig. 1a ). For colistin we did not observe a higher MIC after 4 days nor at 10 days of treatment, indicating a clear difference in response to the antibiotics used ( Fig 1A, Supplementary Fig 1A) .
To comprehensively survey cellular signaling at early stages of antibiotic treatment and early resistance development, label-free quantification of both proteome and phosphoproteome was performed ( Supplementary Fig. 1 ). Due to the lack of a clear resistant phenotype at 10 days of colistin treatment, we focused our (phospho)proteome analysis to the 4 day time point, in order to get insight into the early onset effects of colistin treatment. At a false discovery rate (FDR) of 1% at the protein level, this resulted in the identification of 2,850 proteins ( Supplementary Table 1 ), from which 2,567 were quantified, achieving a similar coverage as previous E. coli proteome studies, but within a significant shorter analysis time (24) . Moreover, similar Gene Ontology (GO)
profiles were obtained at the proteome and genome levels, confirming the completeness of our proteome coverage ( Supplementary Fig. 2 ). We next evaluated these protein expression patterns to detect differential expression related to antibiotic treatment and resistance. Principle component analysis of colistin and ciprofloxacin proteome data clearly segregated samples into three groups. Furthermore the analysis indicated that the serially-passaged E. coli treated with low dose of colistin are closer related to mcr-1-positive cells than to untreated cells, despite the lack of a clear resistant phenotype in serially passaged colistin treated E.coli (Fig. 1A and 1B ). As expected, the phosphoethanolamine (pEtN) transferase coded by mcr-1 (pEtN trans) was only identified in the mcr-1 clinical strain ( Fig 1C) . Surprisingly, several classes of proteins known to be involved in resistance exhibited significant changes in expression upon colistin treatment as well as in the mcr-1 cells. The multidrug efflux pump (AcrA) as well as a variety of proteins involved in cell wall biogenesis, such as the Bam protein complex (25) , LPS assembly outer membrane protein LptE (26) , and the peptidoglycan biosynthesis proteins (MltA and MltB) (27) were more expressed in colistin serially-passaged as well as in mcr-1 cells ( Fig. 1c and Supplementary Table 2 ). Furthermore, the glycolysis/gluconeogenesis pathway and protein translation were down regulated both treated and resistant cells, which is consistent with the concept of compensatory fitness cost in developing resistance (28, 29) ( Fig. 1C and Supplementary   Table 2 ).
For induced ciprofloxacin resistance, similar regulation patterns were observed, as expression levels of lipoproteins (n=22) or proteins involved in cell wall biogenesis (n=21) and cell cycle (n=19) were highly increased when antibiotic susceptibility decreased ( Fig. 1D and Supplementary   Table 2 ). In agreement with ciprofloxacin targeting DNA gyrase activity, a significant number DNA repair system proteins (n=21) were increasingly expressed when resistance developed ( Fig.   1D and Supplementary Table 2 ). Compared to colistin, ciprofloxacin induced the expression of a different panel of multidrug efflux system proteins including MdtK, EmrA, SbmA, and MdlA proteins, which can be explained by the different nature of both antibiotics.
Bacterial protein phosphorylation is far more widespread than anticipated
Bacteria, as well as other organisms, have developed several phosphorylation dependent systems to adapt to environmental stresses, including the well-known two-component system, which constitutes one of the most sensitive and efficient regulatory mechanisms in bacteria. To get detailed insight into differential phosphorylation associated with antibiotic treatment, changes in antibiotic susceptibility and resistance we subsequently profiled the phosphoproteomes of all samples ( Supplementary Fig. 1 ). Our analysis resulted in the identification of 2,509 class I phosphosites (unambiguously localized) on 1,133 proteins (Supplementary Table 3 ). In contrast to commonly used phosphoproteomics workflows, which are usually based on the combination of fractionation and phosphopeptide enrichment (30, 31) , all experiments here were performed in triplicate, which was sufficient to saturate the number of sites ( Supplementary Fig. 3 ) with high quantification accuracy and reproducibility (Pearson correlation coefficient between 0.982 and 0.919, Supplementary Fig. 4 ). In total, we quantified 3,872 phosphopeptides, which span around four orders magnitude of peptide ion signal, allowing us to look beyond classically observed phosphorylations on high abundant metabolic enzymes ( Fig. 2A) . In fact, phosphorylation events on several transcription factors and those indicating kinase activity were identified in the lowestabundance-range of the distribution We therefore hypothesized that the dynamics of phosphorylation signaling networks induced by antibiotics could be well profiled ( Fig. 2A) . The comprehensive and parallel measurements of phosphoproteome and proteome allowed us, for the first time, to investigate a possible correlation between a protein's abundance and its propensity to be phosphorylated. There is a weak but significant tendency between the number of identified phosphosites and increasing protein abundance (Fig. 2B , Pearson correlation as 0.65, p <0.01) which is similar to the profile in the human phosphoproteome (32) . About 45% of identified proteins were phosphorylated on just one residue, whereas the remaining 55% were phosphorylated at multiple sites (Fig. 2C ). In addition, the GO term enrichment of identified phosphorylated proteins correlates with the obtained proteome profile suggesting that we achieved a comprehensive phosphoproteome coverage ( Supplementary Fig. 2) . Moreover, the residuespecific phosphorylation pattern observed (Ser 56%, Thr 20%, Tyr 13%, Asp 5%, and His 5%; Fig. 2D ) closely corresponds to previous published reports (33) . When compared to the two existing databases, dbPSP and Uniprot, the work described here expands the known E. coli phosphoproteome by a factor 4 and as a result, 89.6 % of identified phosphosites (n=2248) were observed for the first time ( Fig. 2E) (34) . Overall, this work indicates that bacterial phosphorylation is far more widespread than anticipated, as 40% of the identified proteins are phosphorylated.
In-depth quantitative phosphoproteomics enables identification of potential regulators in resistance development
PCA analysis of the phosphoproteome data again segregated the E. coli cells according to antibiotic susceptibility (Fig. 3A, B ). For ciprofloxacin, phosphoproteomes of 7 day treated cells were more distinct from the 3 days and non-treated treated cells. Surprisingly, for colistin, the 4 days treated cells resembled the resistant mcr-1 cells, again despite the presence of a clear resistant phenotype, but in accordance with the proteome data. These results suggest that specific regulation at the phosphorylation level takes place upon antibiotics treatment, driving to a resistance-like phenotype (Fig. 3A) . Indeed, a high percentage of identified phosphosites showed significant differential regulation during treatment and resistance: 460 phosphosites were significantly regulated in the colistin samples, while 911 were regulated upon ciprofloxacin treatment (ANOVA test, FDR< 0.05; Supplementary Table 4 ).
When looking closely at the significantly regulated phosphosites, we identified phosphorylation changes on several known resistance-related proteins. We observed increased phosphorylation of His717 on the ArcB sensor protein upon colistin treatment, a finding which is in agreement with previous studies showing that colistin stimulates the production of highly deleterious hydroxyl radicals, inducing high activity of the ArcAB two-component system as a resistance mechanism (35, 36) . Phosphorylation levels of proteins involved in DNA transfer (relaxosome proteins : TraD, TraP) and integration host factor (IhfA)) (37), universal stress proteins (UspB and UspG) (38), Psp system (PspA and PspC) (39) , and drug efflux proteins (OmpT) (40) , were also regulated in the colistin serially-passaged E. coli ( Fig. 3C and Supplementary Table 4 ).
Similarly, differential phosphorylation of known resistance-related proteins was observed upon ciprofloxacin treatment ( Fig. 3D and Supplementary Table 4 ), for example on the DNA transferrelated proteins (TraM, IhfA, and IhfB), stress response proteins (UspA, UspF, and UspG) (38), psp system (PspA) (39) , and the antibiotics degrading enzyme AmpC. Interestingly, phosphorylation of several DNA repair proteins (UvrA, UvrB, and UvrC) was significantly downregulated in ciprofloxacin resistant cells, implying that these phosphorylation events play a role in combating the effect of ciprofloxacin, which is a DNA gyrase inhibitor (Fig. 3D) . ABC transporter and two-component system pathways, which are known to be related to evolution of resistance (14, 41) , were significantly regulated in both colistin and ciprofloxacin treatments ( Fig.   4 ). Though signal transduction via two-component systems is known to rely on reversible phosphorylation (12) , regulated phosphosites identified here are mostly unknown, suggesting that the detailed signaling mechanisms underlying response and resistance to antibiotics are currently underestimated.
Furthermore, we identify for the first time enriched phosphorylation motifs in different regulatory clusters, implying that specific kinase/phosphatase systems are involved in antibiotic response and resistance (Fig. 3C, D) . As an example, we observed the motif KxxS, matching to the HipA kinase's substrate motif, on Ser239 of the GltX protein. Interestingly, the HipA kinase was phosphorylated at both Ser150 and Asp146, albeit respectively up-and down-regulated during antibiotic treatment, suggesting that those two phosphosites may play a role in the regulation of the kinase function during resistance development (42) . In addition, several specific tyrosine phosphorylation motifs were identified, suggesting the potential importance of tyrosine kinaseinduced phosphorylation in resistance evolution (Fig. 3C, D) . Protein phosphorylation occurring in the proximity of the protein N-or C-terminus was highly enriched, consistent with findings in a previous study (33) . We here demonstrate the possible importance of these terminal phosphorylation events in resistance development (Fig. 3C, D) . As such terminal phosphorylation events are possibly bacteria specific, the kinases responsible for these phosphorylations could represent adequate drug targets.
Regulated phosphosites involved in DNA transcription display evolutionary high conservation across bacterial species
Phosphorylation on DNA transcriptional regulators is of particular interest because of its potential to influence bacterial cell growth and pathogenicity (13) . This spurred us to assess the residue conservation among regulated phosphosites identified on known transcription factors, as a high level of conservation can indicate conserved biological function (13) . Amongst identified regulated phosphosites, several residues on winged helix-turn-helix (HTH) DNA binding domains were highly conserved in proteobacteria. This includes residues on the C-terminal effector domain of the OmpR/PhoB subfamily transcription regulators such as Thr191, His200 and Ser202 residues on CpxR, Tyr194 on OmpR, and Ser214 and Tyr226 on BaeR (Fig. 5 ). Other evolutionary conserved phosphosites on HTH domains were observed at Thr141, Ser180, and Thr209 of Crp as well as on Thr2 of the AscG transcription regulator (Fig. 5 ). Our data thus suggest that protein phosphorylation in the HTH region might be a widespread mechanism of transcriptional control of genes implicated in antibiotic resistance.
Phosphosites identified on transcription regulators such as Tyr64 and Tyr 146 on RcsB, Ser282
on CysB, Ser3 on SlyA, Thr62, Thr126, Ser129, and Ser135 on YebC, and His230 on YeiE were also found to be highly conserved among bacterial orthologues ( Supplementary Fig. 5 ). The observed upregulation of the conserved transcriptional regulatory protein RcsB phosphosites, Tyr64 and Tyr146, for colistin serially-passaged cells is consistent with previous reports establishing a link between the RcsCDB/F phospho-relay system and polymyxin resistance (43) .
In the same manner, high conservation of phosphorylated residues was found on other DNA binding proteins, including Hns, StpA, HupA, and HupB, in which regulated phosphosites located both on DNA binding or protein dimerization domains were found to be all highly conserved across bacteria (Fig. 6) . Interestingly, the hns protein has been linked to multidrug resistance (44) and together with protein StpA coordinates OmpF porin gene expression and DNA conjugation in order to cope with environmental stress such as antibiotic administration (45, 46) . In addition, histone-like proteins HupA and HupB are the most common bacterial DNA-binding proteins responsible for nucleoid compaction, therefore dynamic phosphorylation events located on DNA binding region and the N-terminal tail might be similar to eukaryotic histones phosphorylations and serve as sensors of cellular stress, ultimately leading to resistance-related gene expression (47) .
Therefore, the well-known eukaryotic histone-code may have a prokaryotic counter-part
Discussion
The concept that regulated protein phosphorylation in its various facets could contribute to defining new drug targets is not new per se. However, the thorough investigation of phosphorylation signaling pathways in bacteria has been mostly neglected. Here we present the broadest bacterial phosphorylation catalogue, representing 2509 phosphosites. Notably, the extent of phosphorylation regulation in bacteria is far more important than we anticipated and the fact that only 10.4% of identified phosphosites (n=261) are reported in the public databases, Uniprot and dbPSP, make this study a valuable resource for future, indispensable, work on deciphering signaling mechanisms involved in AMR.
We showed for the first time that specific phosphorylation motifs changed during resistance development. This is consistent with the idea that bacterial Ser/Thr/Tyr kinases are involved in resistance development (48) , which has been proposed but never comprehensively studied.
Moreover, regulated phosphorylation sites located on transcription factors and other DNA binding proteins showed high evolutionary conservation, indicating an important biological role.
Finally, upon resistance development, we also observed specific regulation of N/C-terminal phosphorylation, which is unique to bacteria. Together, these regulated phosphorylation events during antibiotic treatment and resistance indicate that phosphorylation mediated signaling could be used as a specific target for drug design. In summary, we here describe the most comprehensive coverage of a bacterial phosphoproteome and monitor its dynamics upon 
